MARC at the University of Colorado Denver
MARC at the University of Colorado Denver
批准号:
10642383
负责人:
RICHARD M ALLEN
金额:
$15.09万
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-06-01 至 2028-05-31
关键词:
AddressBachelor&aposs DegreeBiomedical ResearchCCL7 geneColorColoradoCommunicationCommunity HealthcareDegree CompletionDevelopmentDisparityEducational StatusEligibility DeterminationEnrollmentEquityFundingGoalsInstitutionInvestmentsK-Series Research Career ProgramsKnowledgeMedicalMentorsOutcomePopulationPositioning AttributeProgram EvaluationResearchScienceStructureStudentsSystemThinkingTrainingTraining ActivityUnderrepresented PopulationsUnited StatesUniversitiesbasecareercareer developmentexperiencehigher educationimprovedinnovationlife-long learningmatriculationmodel buildingoutcome disparitiesprogramsresilienceskill acquisitionskillssuccessundergraduate researchundergraduate studentunderrepresented minority student
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY
The diversity of the United States population is not reflected in its biomedical sciences workforce, with the
greatest disparities at the highest levels of degree attainment and in careers that require advanced degrees.
Institutions of higher education have both the capacity and the imperative to address the structural barriers that
create inequitable outcomes in degree attainment for underrepresented populations, both at the undergraduate and
graduate levels of education. The University of Colorado Denver (CU Denver) is unique and uniquely positioned
to meet this goal. CU Denver (comprised of the downtown Denver campus and the Anschutz Medical Campus) is
a “Doctoral University: Higher Research Funding” with a funding portfolio of $790 million and a combined
enrollment of 19,395 students. It is the only public urban research university in the State of Colorado and the most
diverse institution in the CU system: on the Denver campus, at least 58% of incoming first-year students identify
as students of color and 43% as underrepresented minority students. CU Denver's commitment to equity, lifelong
learning, innovation, research excellence, and community care underlie its record of investment in undergraduate
research and improving student success outcomes, including the timely graduation of undergraduate students and
their transition into doctoral programs in biomedical sciences. The purpose of the CU Denver Maximizing Access
to Research Careers program proposed here (MARC at CU Denver) is to continue this record of excellence and
further contribute to the development of a diverse and inclusive national biomedical research workforce by
providing underrepresented, honors-eligible undergraduate science majors with the courses, structured training
activities, mentoring, and authentic research experiences necessary to transition successfully into research-focused
biomedical doctoral programs. With prior funding and institutional support, CU Denver has spent nearly a decade
developing, implementing, evaluating, and refining a successful training model that builds trainees' science
knowledge and scientific thinking skills, research experience, communication and networking skills, sense of
belonging and wellness skills, and career development skills. With continued institutional support and a record of
success with a similar program, a new MARC at CU Denver program will support 30 trainees over five years
such that 90% or more will complete their baccalaureate degrees in a biomedical science related field at CU
Denver (80% or more in two years after joining the program) and 60% or more will matriculate into doctoral
programs in biomedical science within three years of graduating, with an 80% doctoral program completion rate.
The success of MARC at CU Denver is bolstered through institutional support for a base-building “pre-MARC”
program for first and second-year students, scholar wellness and resiliency training and support, and continued
external program evaluation. The scope of MARC at CU Denver is broadened through direct institutional support
for additional senior CU Denver MARC Affiliate Scholars.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
UC Denver MARC U-STAR
-
批准号:10405592
-
项目类别:
-
资助金额:$29.99万
-
财政年份:2013
-
负责人:RICHARD M ALLEN
-
依托单位:
UC Denver MARC U*STAR Scholars Program
-
批准号:8663927
-
项目类别:
-
资助金额:$14.93万
-
财政年份:2013
-
负责人:RICHARD M ALLEN
-
依托单位:
UC Denver MARC U*STAR Scholars Program
-
批准号:9054866
-
项目类别:
-
资助金额:$15.14万
-
财政年份:2013
-
负责人:RICHARD M ALLEN
-
依托单位:
UC Denver MARC U*STAR Scholars Program
-
批准号:8475235
-
项目类别:
-
资助金额:$14.84万
-
财政年份:2013
-
负责人:RICHARD M ALLEN
-
依托单位:
UC Denver MARC U*STAR Scholars Program
-
批准号:9271198
-
项目类别:
-
资助金额:$12.55万
-
财政年份:2013
-
负责人:RICHARD M ALLEN
-
依托单位:
UC Denver MARC U*STAR Scholars Program Supplement
-
批准号:10393993
-
项目类别:
-
资助金额:$8.64万
-
财政年份:2013
-
负责人:RICHARD M ALLEN
-
依托单位:
UC Denver MARC U*STAR Scholars Program
-
批准号:8842134
-
项目类别:
-
资助金额:$15.04万
-
财政年份:2013
-
负责人:RICHARD M ALLEN
-
依托单位:
RELATIONS BETWEEN URINE AND SERUM MEASURES OF IRON STATUS
-
批准号:7607481
-
项目类别:
-
资助金额:$0.07万
-
财政年份:2006
-
负责人:RICHARD M ALLEN
-
依托单位:
HYPOCRETIN, HISTAMINE AND THE RESTLESS LEGS SYNDROME
-
批准号:7607466
-
项目类别:
-
资助金额:$1.4万
-
财政年份:2006
-
负责人:RICHARD M ALLEN
-
依托单位:
HISTAMINE AND THE RESTLESS LEGS SYNDROME
-
批准号:7607494
-
项目类别:
-
资助金额:$0.06万
-
财政年份:2006
-
负责人:RICHARD M ALLEN
-
依托单位:
HYPOCRETIN, HISTAMINE AND THE RESTLESS LEGS SYNDROME
-
批准号:7375820
-
项目类别:
-
资助金额:$0.7万
-
财政年份:2005
-
负责人:RICHARD M ALLEN
-
依托单位:
HYPOCRETIN, HISTAMINE AND THE RESTLESS LEGS SYNDROME
-
批准号:7204455
-
项目类别:
-
资助金额:$14.37万
-
财政年份:2004
-
负责人:RICHARD M ALLEN
-
依托单位:
Hypocretin, Histamine and the Restless Legs Syndrome
-
批准号:7045665
-
项目类别:
-
资助金额:$3.2万
-
财政年份:2003
-
负责人:RICHARD M ALLEN
-
依托单位:
Escalating Cocaine Self-Administration: NMDA Mechanisms
-
批准号:6543860
-
项目类别:
-
资助金额:$7.1万
-
财政年份:2002
-
负责人:RICHARD M ALLEN
-
依托单位:
Escalating Cocaine Self-Administration: NMDA Mechanisms
-
批准号:6608599
-
项目类别:
-
资助金额:$7.1万
-
财政年份:2002
-
负责人:RICHARD M ALLEN
-
依托单位:
NMDA RECEPTOR ANTAGONISTS AND OPIOID TOLERANCE
-
批准号:2796438
-
项目类别:
-
资助金额:$1.7万
-
财政年份:1998
-
负责人:RICHARD M ALLEN
-
依托单位:
NMDA RECEPTOR ANTAGONISTS AND OPIOID TOLERANCE
-
批准号:2516476
-
项目类别:
-
资助金额:$1.67万
-
财政年份:1998
-
负责人:RICHARD M ALLEN
-
依托单位: